Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

Do you suffer from knee pain during or after movement? Does knee pain limit your mobility or prevent you from enjoying some activities you previously found joy in? There is mounting evidence that ...

For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and ...

The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for the treatment of osteoarthritis of the knee. GNSC-001 is an investigational, adeno-associated virus gene ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

Cymbalta (duloxetine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) that can be used as a second-line treatment for knee OA. In addition to regulating mood, this antidepressant has been ...

Experts note that short of knee surgery, this staggering reduction ... Semaglutide can be doubly effective as a treatment for osteoarthritis. It helps patients lose weight while decreasing ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.